LEADER 01477nam  2200373z- 450 
001 9910689605003321
005 20161209103610.0
035   $a(CKB)5860000000021151
035   $a(BIP)010573379
035   $a(EXLCZ)995860000000021151
100   $a20220406c2004uuuu  -u-         -
101 0 $aeng
200 10$aDirect to consumer advertising (DTC) $ehearing before the Subcommittee on Consumer Affairs, Foreign Commerce, and Tourism of the Committee on Commerce, Science, and Transportation, United States Senate, One Hundred Seventh Congress, first session, July 24, 2001
215   $a1 online resource (iii, 67 p.) $cill
311   $a0-16-071396-X 
517   $aDirect to consumer advertising 
606   $aAdvertising$xDrugs$zUnited States
606   $aDrugs$xMarketing$zUnited States
606   $aPrescription pricing$zUnited States
606   $aConsumer protection$zUnited States
610   $aAdvertising
610   $aDrugs
610   $aConsumer protection
610   $aBusiness & economics
610   $aReference
615  0$aAdvertising$xDrugs
615  0$aDrugs$xMarketing
615  0$aPrescription pricing
615  0$aConsumer protection
712 02$aUnited States, Congress Senate Committee on Commerce, Science, and Transportation Subcommittee on Consumer Affairs, Foreign Commerce, and Tourism Staff,$4oth
906   $aBOOK
912   $a9910689605003321
996   $aDirect to consumer advertising (DTC)$93184289
997   $aUNINA